Results 181 to 190 of about 4,340 (195)

Belinostat

Reactions Weekly, 2013
openaire   +1 more source

Phase II Study of Belinostat (PXD101), a Histone Deacetylase Inhibitor, for Second Line Therapy of Advanced Malignant Pleural Mesothelioma

Journal of Thoracic Oncology, 2009
Suresh S Ramalingam, Chandra P Belani, Christopher Ruel   +2 more
exaly  

Vorinostat and Belinostat, hydroxamate-based anti-cancer agents, are nitric oxide donors

Journal of Inorganic Biochemistry, 2020
Reece G Kenny, Ziga Ude, James R Docherty   +2 more
exaly  

Effects of UGT1A1 genotype on the pharmacokinetics, pharmacodynamics, and toxicities of belinostat administered by 48‐hour continuous infusion in patients with cancer

Journal of Clinical Pharmacology, 2016
Tristan M Sissung, Cody J Peer, Yusuke Tomita   +2 more
exaly  

A phase I study to determine the pharmacokinetics and urinary excretion of belinostat and metabolites in patients with advanced solid tumors

Cancer Chemotherapy and Pharmacology, 2016
Jordan P Mcpherson, Theresa L Werner, Sumati Gupta   +2 more
exaly  

A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours

British Journal of Cancer, 2010
Ulrik Lassen, L Vidal, R T Penson
exaly  

Contribution of UGT1A1, CYP2A6, CYP2C9, and CYP3A4 in metabolism of belinostat

Drug Metabolism and Pharmacokinetics, 2019
Gang Luo, Michael Schicker, Deborah Lee, Sara Leitz, Donald McKenzie, Daniel Albaugh, Guru Reddy   +6 more
openaire   +1 more source

Belinostat/duvelisib

Reactions Weekly
openaire   +1 more source

7105 POSTER DISCUSSION Belinostat in Combination With Carboplatin and Paclitaxel (BelCaP) for Treatment of Bladder Cancer – A Pharmacokinetic Study of Exposure to Belinostat and Its Metabolites

European Journal of Cancer, 2011
R.J. Jones, J. Tjornelund, K.D. Erichsen, L. Sengelov, J. De Bono   +4 more
openaire   +1 more source

Pharmacokinetics, metabolism, and excretion of 14C-labeled belinostat in patients with recurrent or progressive malignancies

Investigational New Drugs, 2016
Emiliano Calvo, Guru Reddy, Mi Rim Choi   +2 more
exaly